News
Ladder Capital Corp ("Ladder" or the "Company") (NYSE: LADR) today announced the declaration by its board of directors of a third quarter 2025 dividend of $0.23 per share of Class A common stock. The ...
The bill was written as a sweeping piece of legislation designed to combat the swell of antisemitic incidents across K-12 ...
The Warhammer 40k Space Marine 2 update 10.0 patch notes reveal that the developers have finally added the much-awaited ...
PLANO, TX / ACCESS Newswire / September 11, 2025 / BGSF, Inc. (NYSE:BGSF) (“BGSF” or “the Company”), a leading provider of workforce solutions for the specialized property management industry, today ...
Discreetly affixed to the underside of the Thomas & Mack Center’s center-hung scoreboard were 12 custom-built antennas. Two ...
Speaking more specifically on PEs, allowing 401 (k) participants to access an asset class that has historically generated ...
HIGH POINT, N.C., Sept. 15, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company, today ...
The Strive, Inc. ("Strive"; Nasdaq: ASST) board, chaired by CEO Matt Cole, is stacked with experienced Bitcoin executives ...
Kuwait Financial Centre “Markaz” has announced the launch of its Private Real Assets Strategy, a global investment solution ...
Inquiries about the Derivative Actions or the Settlement may be made to: Timothy Brown, The Brown Law Firm, P.C., 767 Third Avenue, Suite 2501, New York, NY 10017, Telephone: (516) 922-5427, Email: ...
Extended Half-Life: OPK-8801003 GLP-2 tablet demonstrated a plasma half-life of approximately 15 hours in minipigs, representing an approximate 18-fold improvement over teduglutide, which has a ...
ERNA-101 is the company’s lead cell therapy product, designed to activate and regulate the immune system's response to recognize and attack cancer cells. ERNA-201 is a cell therapy product designed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results